Statements (58)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Oncology
|
| gptkbp:can_cause |
gptkb:Nausea
Diarrhea Fatigue Weight loss Constipation |
| gptkbp:can_lead_to |
Lymphadenopathy
Ascites Peritoneal carcinomatosis |
| gptkbp:death |
5-year survival rate is approximately 47%
|
| gptkbp:diagnosis |
Biopsy
Ultrasound CT scan Pelvic examination |
| gptkbp:has_type |
gptkb:Clear_cell_carcinoma
gptkb:Endometrioid_carcinoma gptkb:Mucinous_carcinoma gptkb:Serous_carcinoma |
| https://www.w3.org/2000/01/rdf-schema#label |
Epithelial ovarian cancer
|
| gptkbp:is_associated_with |
gptkb:BRCA1_mutation
gptkb:BRCA2_mutation gptkb:Lynch_syndrome gptkb:Peutz-Jeghers_syndrome |
| gptkbp:is_common_in |
gptkb:women
African American women Asian women Caucasian women |
| gptkbp:is_monitored_by |
Blood tests
Imaging tests Regular follow-up exams |
| gptkbp:is_part_of |
Gynecologic oncology
|
| gptkbp:is_related_to |
Environmental factors
Genetic predisposition Hormonal factors |
| gptkbp:is_studied_in |
Clinical trials
|
| gptkbp:number_of_stages |
Stage I
Stage II Stage III Stage IV |
| gptkbp:risk_factor |
gptkb:Endometriosis
Obesity Family history of ovarian cancer Age over 50 |
| gptkbp:screenings |
CA-125 blood test
Transvaginal ultrasound |
| gptkbp:symptoms |
Pelvic pain
Abdominal bloating Difficulty eating Urinary urgency |
| gptkbp:treatment |
gptkb:Cure
gptkb:surgery Chemotherapy Radiation therapy Platinum-based chemotherapy Palliation Taxane chemotherapy |
| gptkbp:bfsParent |
gptkb:Ovarian_Cancer
|
| gptkbp:bfsLayer |
5
|